SMFL.OTC.PinkSmart for Life, INC

10-Q: Smart for Life Reports Q1 2024 Results: Revenue Declines Amid Strategic Shifts

Sentiment:

Quarterly Report


Smart for Life's Q1 2024 revenue decreased significantly due to cash constraints and a shift in business strategy, alongside ongoing efforts to address internal control weaknesses.

Capital raiseThe company is dependent on raising additional capital through placement of common stock and/or debt financing in order to implement its business plan.There is no assurance that the company will be successful with future financing ventures, and the inability to secure such financing may have a material adverse effect on its financial condition.
Worse than expectedThe company's revenue decreased significantly due to cash constraints and a shift in business strategy.The company has a working capital deficiency of $11.0 million.The company's disclosure controls and procedures were not effective as of March 31, 2024, due to material weaknesses.

Summary

  • Smart for Life, Inc. reported a net loss of $2.9 million for the three months ended March 31, 2024, compared to a net loss of $4.3 million for the same period in 2023.
  • Total revenues decreased by 70.18% to $478,907, primarily due to a decline in nutraceutical product sales and advertising revenue.
  • The company is focused on a buy-and-build strategy, acquiring companies to create a vertically integrated business.
  • Smart for Life is working to remediate material weaknesses in its internal control over financial reporting.
  • The company is dependent on raising additional capital to fund its business plan.
  • The company sold nearly all of the assets of Ceautamed for a 49% ownership interest in First Health FL LLC, which was subsequently sold for $1.00.
  • The company entered into a securities purchase agreement to acquire Purely Optimal Nutrition Inc. for $11.9 million.
  • The company completed a warrant solicitation, receiving net proceeds of approximately $458,473.
  • As of March 31, 2024, the company had cash of $21,331 and a working capital deficiency of $11.0 million.

Sentiment

Score: 4

Explanation: The document presents a mixed picture. While the net loss has decreased, the significant revenue decline, working capital deficiency, and material weaknesses in internal control raise concerns. The potential acquisition and warrant solicitation are positive developments, but the company's dependence on raising additional capital adds uncertainty.

Positives

  • The net loss decreased by $1.4 million compared to the same period last year.
  • The company completed a warrant solicitation, receiving net proceeds of approximately $458,473.
  • The company is actively working to remediate material weaknesses in its internal control over financial reporting.
  • The company is focused on a buy-and-build strategy, acquiring companies to create a vertically integrated business.

Negatives

  • Total revenues decreased by 70.18% to $478,907.
  • The company has a working capital deficiency of $11.0 million.
  • The company is dependent on raising additional capital to fund its business plan.
  • The company's disclosure controls and procedures were not effective as of March 31, 2024, due to material weaknesses.

Risks

  • The company's ability to continue as a going concern is in substantial doubt.
  • The company is dependent on raising additional capital, and there is no assurance that it will be successful.
  • Material weaknesses in internal control over financial reporting could adversely affect the company's ability to record, process, summarize, and report financial information.
  • The company is involved in various lawsuits and legal proceedings, which could harm its business.
  • The company's success depends on its ability to acquire new customers or retain existing customers, offer competitive product pricing, broaden product offerings, and navigate industry demand and competition.

Future Outlook

Management believes that current available resources will not be sufficient to fund planned expenditures over the next 12 months and is dependent on raising additional capital.

Management Comments

  • Management believes that current available resources will not be sufficient to fund our planned expenditures over the next 12 months from the date hereof.
  • Accordingly, we will be dependent upon the raising of additional capital through placement of common stock and/or debt financing in order to implement our business plan.

Industry Context

The company operates in the nutraceutical and affiliate marketing industries, which are subject to intense competition and changing market conditions. The company's performance is affected by its ability to adapt to these changes and maintain a competitive edge.

Comparison to Industry Standards

  • It is difficult to compare Smart for Life's results directly to industry standards due to its unique combination of nutraceutical manufacturing and affiliate marketing.
  • Comparable companies in the nutraceutical manufacturing space include contract manufacturers like Nutra Manufacturing and Reliance Private Label, but their financial disclosures are not always readily available.
  • In the affiliate marketing space, companies like CJ Affiliate and Rakuten Advertising are major players, but their business models and financial scales differ significantly from Nexus Offers.
  • Smart for Life's revenue decline and net loss suggest it is underperforming compared to industry averages, but its strategic shift and acquisition plans could improve its position in the future.

Legal Proceedings

  • On September 9, 2024, the SEC issued an order against the Company which found that the Company entered into two separation agreements with former employees that each contained language violating Rule 21F-17(a) of the Securities Exchange Act of 1934, as amended.

Related Party Transactions

  • The Company entered into debt with related parties which are reflected in Note 8.
  • For the three months ended March 31, 2024 and 2023, the Company paid Trilogy Capital Group, LLC, a company controlled by our Executive Chairman, $0 and $27,547, respectively, for services rendered under a consulting agreement.

Stakeholder Impact

  • Shareholders: The company's financial performance and strategic decisions will directly impact shareholder value.
  • Employees: The company's ability to secure financing and execute its business plan will affect job security and opportunities.
  • Customers: The company's ability to offer competitive product pricing and broaden product offerings will impact customer satisfaction.
  • Creditors: The company's ability to repay its debts is dependent on its financial performance and ability to raise additional capital.

Next Steps

  • The company plans to continue to implement remedial procedures to address the material weaknesses in internal control over financial reporting.
  • The company is working to complete the acquisition of Purely Optimal Nutrition Inc.
  • The company will continue to seek additional capital to fund its business plan.

Key Dates

DateDescription
2017-02-07Smart for Life, Inc. was originally formed in the State of Delaware.
2018-03-08SMFL acquired 51% of Millenium Natural Manufacturing Corp. and Millenium Natural Health Products, Inc.
2019-10-08SMFL entered into an agreement to acquire the remaining 49% of Millenium Natural Manufacturing Corp. and Millenium Natural Health Products, Inc.
2020-09-30The name of Millenium Natural Manufacturing Corp. was changed to Bonne Sante Natural Manufacturing, Inc.
2020-06The Company entered into a promissory note with the U.S. Small Business Administration with a principal amount of $300,000.
2021-02The Company received an additional $261,164 in PPP loans under the CARES Act.
2021-07-01SMFL acquired Doctors Scientific Organica, LLC d/b/a Smart for Life, Oyster Management Services, Ltd., Lawee Enterprises, L.L.C. and U.S. Medical Care Holdings, L.L.C.
2021-08-27SMFL transferred all of the equity interests of Oyster Management Services, Ltd., Lawee Enterprises, L.L.C. and U.S. Medical Care Holdings, L.L.C. to Doctors Scientific Organica, LLC.
2021-11-08SMFL acquired 100% of Nexus Offers, Inc.
2021-12-06SMFL acquired 100% of GSP Nutrition Inc.
2022-05-19SMFL acquired Lavi Enterprises, LLC and transferred all of the equity interests of Lavi Enterprises, LLC to Doctors Scientific Organica, LLC.
2022-07-29SMFL acquired Ceautamed Worldwide, LLC and its wholly-owned subsidiaries Wellness Watchers Global, LLC and Greens First Female LLC.
2023-04-24The Company effected a 1-for-50 reverse stock split of its outstanding common stock.
2023-08-02The Company effected a 1-for-3 reverse stock split of its authorized and outstanding common stock.
2023-10-27The Company effected a 1-for-3 reverse stock split of its authorized and outstanding common stock.
2024-01-08The retail store location of Smart for Life Canada Inc. was closed.
2024-01-29The Company entered into an asset purchase agreement to sell nearly all of the assets of Ceautamed for a 49% ownership interest in First Health FL LLC.
2024-03-06The Company entered into a sale and leaseback agreement relating to BSNM.
2024-04-03The Company entered into a securities purchase agreement with Purely Optimal Nutrition Inc. to acquire all of the issued and outstanding membership interests of Purely Optimal.
2024-04-22The Company effected a 1-for-7 reverse stock split of its authorized and outstanding common stock.
2024-05-30The Company entered into warrant solicitation inducement letters with the holders of warrants for the purchase of an aggregate of 183,370 shares of common stock.
2024-06-03The closing of the warrant solicitation transaction was completed, and the Company issued the New Warrants.
2024-09-09The SEC issued an order against the Company which found that the Company entered into two separation agreements with former employees that each contained language violating Rule 21F-17(a) of the Securities Exchange Act of 1934, as amended.
2024-10-01The 51% owner of First Health elected to exercise the option to purchase the remaining 49% interest in First Health from the Company.
2025-03-31The Nasdaq Stock Market LLC (Nasdaq) filed a Form 25 with the U.S. Securities and Exchange Commission to complete the delisting of the Company's common stock from The Nasdaq Capital Market, which became effective on March 31, 2025.
2025-05-09As of this date, there were 7,090,728 shares of the registrant's common stock issued and outstanding.

Keywords

financial results, revenue, net loss, acquisition, internal control, going concern, warrant solicitation, nutraceutical, debt, liquidity

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.